Experts and guidelines recommend vesicular monoamine 2 transporter (VMAT2) inhibitors as the best option for treating more severe cases of tardive dyskinesia, an involuntary movement disorder caused ...

Tardive dyskinesia (TD) is a movement disorder linked to neuroleptics, a type of antipsychotic drug. Some studies suggest 20 to 50% of people taking neuroleptics develop TD during treatment, and it ...

Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...

Study reveals over half of long-term care residents with tardive dyskinesia do not receive standard treatment, highlighting care gaps. Less than half of patients diagnosed with tardive dyskinesia in ...

In 2024, several research and pharmacological advancements were made for tardive dyskinesia, a movement disorder caused by dopamine-blocking medications. Below are some of the highlights of the year.

(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced results from a study of treatment patterns among patients with tardive dyskinesia (TD) ...

Tardive dyskinesia stigma can negatively impact your life, but experts say there are a number of ways to lessen its effects.

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify iwaters@healio.com if there are concerns ...

Tardive Dyskinesia TD as a neurological disorder resulting in involuntary repetitive movement disorder as a disease of brain Neurology due to dopamine problems. What have studies said the role vitamin ...

Why Teva’s new tardive dyskinesia data matters for shareholders Teva Pharmaceutical Industries (NYSE:TEVA) has put its neuroscience work in the spotlight by releasing new real world data from the ...

LONDON--(BUSINESS WIRE)--The global tardive dyskinesia treatment market 2019-2023 is expected to post a CAGR of more than 4% during the forecast period, according to the latest market research report ...

DUBLIN--(BUSINESS WIRE)--The "Global Tardive Dyskinesia Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The Global Tardive Dyskinesia Treatment Market is ...